Derm Flashcards
Acne Vulgaris definition, sx, dx, tx
Inflammatory skin condition associated w/ papules & pustules involving the pilosebaceous units
PATHO: 4 main factors
- follicular hyperkeratinization
- increased sebum production
- Propionibacterium acne overgrowth
- inflammatory response
sx
Commonly seen in areas w/ increased sebaceous glands (face, back, chest, upper arms)
Comedones: small, noninflammatory bumps from clogged pores; surrounding erythema
*open (blackheads) – incomplete blockage
*closed (whiteheads) – complete blockage
Inflammatory: papules or pustules surrounded by inflammation
Nodular or cystic: often heals w/ scarring or hyperpigmentation
dx
Mild: <20 comedones, <15 inflammatory lesions, total <30
Moderate: 20-100 comedones, 15-50 inflammatory lesions, total 30-125
Severe: >100 comedones, >50 inflammatory lesions, >5 cysts, total >125
tx
Mild: topical retinoids (tretinoin, adapalene, tazarotene) + benzoyl peroxide (use at different time of day than retinoids); topical abx also used (erythromycin, clindamycin) *AVOID abx (topical & PO) as monotherapy
Moderate: PO abx + BPO &/or topical retinoids
*>8y: tetracycline, doxycycline, minocycline
*<8y: erythromycin, azithromycin, TMP-SMX
*hormones: OCPs, spironolactone
Severe (refractory nodular acne): PO isotretinoin
Isotretinoin MOA
MOA: all 4 of the pathophysiological mechanisms of acne (most effective medication)
Indications: usually reserved for severe or refractory acne
ADRs
*dry skin & lips (MC), dry eyes
*highly teratogenic
*must obtain 2 (-) pregnancy tests prior to initiation
*pregnancy tests q monthly while on treatment
*must commit to 2 forms of contraception (used 1mo prior-1mo after D/C)
*↑ triglycerides & cholesterol
*arthralgias, myalgias, hepatitis, leukopenia, premature long bone closure
*photosensitivity, worsening of DM, HA, idiopathic intracranial HTN, fatigue, possibly psychiatric
*due to severe risk of teratogenesis, prescribers & patients must sign up for iPledge
Androgenic Alopecia definition, sx, dx, tx
Genetically predetermined progressive loss of the terminal hairs on the scalp in a characteristic distribution (pattern)
MC type of hair loss in men & women; gradual in onset & usually occurs after puberty
M 20-40y, W >50y
PATHO:
*DHT is the key androgen; activation of the androgen receptor shortens the anagen (growth phase) in the normal hair growth cycle
*pathologic specimens show decreased anagen to telogen ratio
sx
Varying degrees of hair thinning & nonscarring hair loss
Males: begins as bitemporal thinning of the frontal scalp then involves the vertex
Females: thinning of the hair between the frontal & vertex of the scalp w/o affecting the frontal hairline
dx
Clinical
Dermoscopy: miniaturized hair & brown perihilar casts
BX: telogen & atrophic follicles
Trichogramma: ↑ telogen hairs
Hormones: testosterone, DHEA, prolactin
Treatable: thyroid (TSH), anemia (CBC), autoimmune (ANA)
tx
Topical minoxidil – 4-6mo trial before improvement
*MOA: vasodilator
*ADRs: pruritis & local irritation w/ flaking
Oral finasteride: 5-⍺-reductase type 2 inhibitor
*MOA: androgen inhibitor (inhibits conversions of testosterone to DHT)
*ADRs: ↓ libido, sexual or ejaculatory dysfunction, ↑ risk of high-grade prostate cancer, category X
Spironolactone: blocks DHT
Hair transplant
Perioral Dermatitis definition, sx, dx, tx
MC seen in young adult women (20-45)
Risk Factors: hx of topical steroid use, fluorinated toothpaste
sx
Erythematous grouped papulopustules, which may become confluent into plaques w/ scales; may have satellite lesions
*classically spares the vermilion border
dx: clinical, redness around the mouth, clear borders
tx
Elimination of topical steroids & irritants
Topical:
- pimecrolimus
- metronidazole
- erythromycin
PO doxycycline if extensive or refractory
Contact Dermatitis definition, sx, dx, tx
Inflammation of the dermis & epidermis from direct contact between a substance & the surface of the skin
Irritant (MC): non-immunologic rxn (immediate)
- chemicals, alcohols, creams
Allergic: type IV hypersensitivity rxn (delayed)
- nickel MC, poison ivy
sx
Acute: erythematous papules or vesicles (may be linear or geometric)
*localized pruritis, stinging, or burning
Chronic: lichenification, fissuring, & scales
*well-demarcated border
dx
Clinical
Patch testing may identify potential allergens
tx
Identification & avoidance of irritants
Topical steroids first line (triamcinolone)
PO steroids in severe or extensive reactions
- alt: topical tacrolimus or pimecrolimus
Diaper Dermatitis definition, sx, dx, tx
Rash on buttocks region; common in infants 3wks-2yrs
Causes: wet, dark, friction, urine, feces, microorganisms
Secondary infections:
*satellite lesions 🡪 candidiasis
*impetigo (S. aureus)
*HSV (child sexual abuse)
dx
*fussiness
*crying w/ diaper change
*diarrhea
*shiny erythema w/ dull margins
*regular diaper dermatitis SPARES SKIN FOLDS
*Candidal diaper rash INVOLVES SKIN FOLDS
dx
Candida: KOH prep, fungal culture
Scabies: viral culture, mineral oil slide
S. aureus, group A strep: culture of skin lesions
*often have concurrent thrush
tx
*keep area dry to allow airflow
*barrier creams: zinc oxide, petroleum jelly
*candidiasis: nystatin, clotrimazole, econazole x2wks
*discuss proper diaper changes, disposable, avoid tight-fitting
Atopic Dermatitis (Eczema) definition, sx, dx, tx
Rash due to defective skin barrier susceptible to drying, leading to pruritis & inflammation
Atopic Triad:
*eczema + allergic rhinitis + asthma
PATHO: disruption of the skin barrier & disordered immune response; onset MC <5yo; resolves/improves in >75% pts by adulthood
Triggers: heat, sweat, allergens, contact irritants
sx
*dry (xerosis), PRURITIC skin
*acute changes: erythema, vesicles, crusting
*chronic changes: lichenification, scaling, hyper/hypopigmentation
*infantile: erythematous, scaly lesions on cheeks, scalp, extensor surfaces; diaper area usually spared
*childhood: lichenified plaques in flexural areas
*adolescence: more localized & lichenified skin changes; may be predominantly on hands/feet
Nummular/Discoid Eczema: sharply defined coin-shaped lesions; dorsum of hands/feet, extensor surfaces
dx
Clinical
↑ IgE supports the dx
tx
Topical steroids first line q1-2x/d x7d for flares
*triamcinolone
Antihistamines for itching
Abx if secondary infection develops
Topical calcineurin inhibitors: second-line
*tacrolimus, pimecrolimus
Systemic: phototherapy (UVA, UVB), cyclosporine, azathioprine, mycophenolate, methotrexate
Lifestyle: avoid products w/ alcohol, fragrances, & astringents; pat skin dry, frequent use of bland lubricants (petroleum jelly, Vaseline, Aquaphor)
Seborrheic Dermatitis definition, sx, dx, tx
PATHO:
*not fully understood, increased sebaceous gland activity + hypersensitivity reaction to Malassezia furfur
-more severe in pts w/ neuro dz (PD) & HIV
-MC in men
-worsen during fall/winter, stress
sx
Erythematous plaques w/ fine white scales & greasy appearance
Common in areas w/ high sebaceous gland secretion – scalp (dandruff), eyelids, beard, mustache, nasolabial folds, chest, groin
May be associated w/ burning & pruritis
dx: clinical
tx
Mild: topical first line
- selenium sulfide
- sodium sulfacetamide
- zinc pyrithione
- ketoconazole (shampoo or cream)
- low potency steroids
Severe or resistant: oral antifungals
- itraconazole, fluconazole, ketoconazole, terbinafine
Burns common causes in infants, toddlers, school age, adolescents
Infants: bathing-related scalds, abuse
Toddlers: scalds by hot liquid spills
School-age: fire (playing w/ matches)
Adolescents: volatile agents, high-voltage electrical lines
Burns rule of 9’s for children
Head: 18%
Front: 18%
Back: 18%
1 arm: 9%
1 leg: 14%
Superficial (First Degree)
*mild inflammatory response confined to epidermis
*redness, DRY
*tenderness to palpation; blanches w/ pressure
*heals 3-6d (no scarring)
Superficial Partial-Thickness (Second Degree)
*epidermis + superficial (papillary) dermis
*pink-red, weeping/MOIST; BLISTERING
*painful, blanches w/ pressure
*heals 7-21d (no scarring, +/- pigment changes)
Deep Partial-Thickness (Second Degree)
*epidermis + deeper (reticular) dermis
*mottled color variation from cheesy white to red
*WET or WAXY; BLISTERING
*painful ONLY w/ pressure, does NOT blanch w/ pressure
*heals 3-9wks (+ hypertrophic scarring)
Full-Thickness (Third Degree)
*epidermis + all of dermis + subQ tissue
*varies, waxy white to leathery gray to charred/black
*DRY, inelastic; no blistering
*lack of sensation; does NOT blanch w/ pressure
*requires surgery for healing
Fourth Degree
*epidermis + dermis + subQ fat + fascia, muscle, bone
*black, CHARRED; dry, no blistering
*no sensation, does NOT blanch w/ pressure
*requires surgery for healing
Burns dx and tx
DIAGNOSTICS:
BSA: superficial (first degree) NOT included
*anterior head 9%, posterior head 9%
*anterior torso 18%, posterior torso 18%
*anterior arm 4.5%, posterior arm 4.5%, total 9%
*anterior leg 7%, posterior leg 7%, total 14%
*genitalia/perineum 1%
Labs: ABG, CBC, CK, CMP, UA, carboxyhemoglobin
tx
*circumferential burns may require fasciotomy
Superficial & superficial partial thickness: wound care
*remove sloughing epidermis w/ gauze & sterile water
*do not rupture blisters
*topical abx (bacitracin) & wound dressing (xeroform)
*daily dressing changes, f/u in 2d
Analgesia: fentanyl, morphine
Td vaccine
Fluid Resuscitation: Parkland Formula, 3ml x TBSA% x wt (kg)
*50% given over first 8h, 50% given over next 16hr
Maintenance Fluids: 4-2-1 Rule
*4ml for first 10kg + 2ml for next 10kg + 1ml for each kg >20
Burn Center Admit Criteria:
*>10% BSA or ANY deep partial/full-thickness burns
*significant burns to hands, face, feet, genitalia/perineum
*electrical, chemical, or inhalational injury
*circumferential burns, underlying chronic condition, abuse
Erythema Multiforme definition, sx, dx, tx
Type IV hypersensitivity reaction of the skin often following infections or medication exposure – MC in young adults 20-40yrs
Etiology:
Infections: HSV MCC; M. pneumoniae, VZV, EBV, CMV, coxsackie, parvovirus B19, M. tuberculosis, Salmonella, HIV
Medications: NSAIDs, sulfonamides, anticonvulsants, antibiotics
CLASSIC target lesions: THREE zones, well defined borders
sx
Target lesions – MC on extremities (hands/feet)
*dusky, violaceous macule or blister
*intermediate surrounding ring of pallor
*peripheral erythematous ring
NON-PRURITIC, blanches
NEGATIVE Nikolsky sign (no epidermal detachment)
Mucositis: typically mild & limited to one mucous membrane (usually oral); conjunctival/urogenital involvement rare
Minor: EM w/o or w/ only mild mucosal dz; NO systemic sxs
Major: EM w/ severe mucosal involvement + systemic sxs (fever, arthralgias)
dx
Clinical
Bx if dx not clear
tx
SELF-LIMITED!!
Symptomatic TX: bland emollients or topical abx applied to eroded areas, IVF for pts w/ mucositis & poor PO intake, antihistamines if pruritic
HSV: acyclovir
If ophthalmic involvement 🡪 REFERRAL
SJS & TEN definition, sx, dx, tx
Rare hypersensitivity reactions affecting the skin & mucosal membranes
Etiology: predominantly drug-related (penicillin, sulfonamides, allopurinol, NSAIDs, anticonvulsants)
*other: infections (M. pneumoniae, influenza)
SJS: <10% BSA
SJS/TEN Overlap: 10-30% BSA
TEN: >30% BSA
ATYPICAL target lesions: TWO zones or poorly defined border
*Generally develops within 2mo of drug initiation, & often within first 1-4wks
sx
Prodrome: fever, malaise, pharyngitis, eye pain
Cutaneous: typically begin on torso & face; rapidly generalizes
SJS: atypical targetoid lesions, often violaceous &/or blistered; lesions may coalesce, particularly on face & torso
TEN: tender, erythematous patches & plaques that develop large bullae that coalesce & rapidly slough, leaving large, denuded areas of skin
(+) Nikolsky sign: applied lateral pressure to blister causes extension of separation from dermis
Mucositis: oropharyngeal, conjunctival, urethral, genital, perirectal; often causes pain, poor PO intake, dehydration
Ocular manifestations: conjunctivitis, eyelid edema, blepharitis, corneal erosions, symblepharon, corneal scarring
dx
Clinical
Bx: full thickness skin necrosis
Consider: bacterial cultures, M. pneumoniae PCR
SJS: <10, most common in children, mainly dt drug reactions, >2 mucous sites, URI prodrome
TEN: >30%, most commonly in elderly, abrupt onset, mucous membrane involvement, positive Nikolsky
tx
PROMP DC OF ALL POSSIBLE INCITING MEDS!!!
Supportive: pain management, nutritional support, maintain normal body temperature, maintain hydration & electrolyte balance
*hypo-Na/K/phos common
Wound care: leave bullae intact, avoid aggressive debridement, petroleum gauze, topical antibiotics, minimize pressure, frequent application of bland emollients/lubricating ointments to involved mucosa, +/- PO disinfectant rinse (chlorhexidine)
IVIG: may be effective at arresting progression
Cutaneous Drug Reactions defintion and types
Medication-induced changes in the skin & mucous membranes – most are hypersensitivity reactions
Most cutaneous drug reactions are self-limited if the offending drug is D/C
Triggers: antigen from foods, insect bites, drugs, environmental, exercise-induced, & infections
Type I: IgE mediated – e.g., urticaria, angioedema; immediate
Type II: cytotoxic, antibody-mediated (drugs + cytotoxic antibodies cause cell lysis)
Type III: immune antibody-antigen complex e.g., drug-mediated vasculitis & serum sickness
Type IV: delayed (cell mediated) – morbilliform reaction e.g., erythema multiforme
Non-immunologic: cutaneous drug reactions d/t genetic incapability to detoxify certain meds (anticonvulsants, sulfonamides)
Exanthematous Drug Eruption definition, sx, dx, tx
Morbilliform or maculopapular drug eruption characterized by macules or small papules after the initiation of drug treatment
MC occurs 5-14d after the initiation of the offending med or within 1-2d in previously sensitized individuals
PATHO: type IV (delayed) hypersensitivity
*MC drugs: antibiotics (aminopenicillins, sulfonamides), anticonvulsants (carbamazepine)
sx
Latency (not previously sensitized): cutaneous eruption typically occurs within 7-10d after starting tx; for short courses of tx (e.g., antibiotics), the eruption may appear 2-4d AFTER stopping tx
Cutaneous features: erythematous macules &/or papules; morbilliform (measles like), rubelliform (rubella like); predominantly involves trunk/proximal extremities
*mild – acral sites often spared
*severe – can involve face, palms/soles
Systemic sxs (mild): pruritis, low-grade fever
dx
CLINICAL DX
Labs: slightly elevated acute phase reactants, mild eosinophilia
tx
Prompt withdrawal of the offending med
Symptomatic: oral antihistamines (H1 blockers)
- second gen: cetirizine, loratadine, fexofenadine
- first gen: diphenhydramine, hydroxyzine, chlorpheniramine
Severe: short course of PO steroids
Angioedema definition, sx, dx, tx
Angioedema
Self-limited, localized subcutaneous (or submucosal) swelling resulting from extravasation of fluid into the interstitium
Affects the mucosal tissues of the face, lips, tongue, larynx, hands, feet, & genitalia
Onset in min-hours w/ spontaneous resolution in hours-few days
sx
Mast-cell (histamine) mediated (e.g., allergic rxns)
*angioedema that may be accompanied w/ other allergic rxn sxs (urticaria, flushing, pruritis, bronchospasm, stridor, throat tightness, hypotension)
Bradykinin-mediated (e.g., ACEI-induced or hereditary – d/t C1 esterase inhibitor deficiency
*angioedema w/o allergic reaction sxs
dx
If there is no information to suggest an external cause & the patient has isolated angioedema (w/o pruritis or urticaria), then C4 levels & a C1 inhibitor antigenic level should be obtained
tx
Immediate: immediate assessment & ongoing airway protection; epi if severe
Mast-cell mediated: epi (if severe), steroids, antihistamines
Bradykinin-mediated: C1 inhibitor concentrate, ecallantide, icatibant